Navigation Links
Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes
Date:4/4/2008

CHAPEL HILL, N.C., April 4, 2008 /PRNewswire/ -- Companies align commercial and portfolio management employees by therapeutic area. For a company with an annual sales volume of $10 to 20 billion, on average nine marketing FTEs are assigned to the early-stage commercialization team along with approximately eight portfolio managers. At companies with smaller sales volumes, the ratio is approximately four to three, commercial to portfolio management staff, according to a study by pharmaceutical benchmarking firm Best Practices, LLC.

In light of a changing industry with heightened focus on research and development, pharmaceutical companies are now significantly increasing resources to support for early-stage commercialization.

The benchmarking report, "Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence," available with a complimentary study summary online at http://www3.best-in-class.com/rr924.htm, provides extensive insight into how pharmaceutical, biotech and medical device companies are preparing their newest employees for the competitive marketplace in which they are being asked to excel.

Best Practices, LLC gathered valuable best practices and operating tactics from leading pharmaceutical companies, including Amgen, Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi-Aventis and Wyeth. They will help executives build and manage strong teams that can excel across functions, units and regions.

Cross-function collaboration is greatly improved through many methods, including structuring jobs with overlapping responsibilities, basing rewards on group performance, designing procedures so that employees with different jobs are better able to collaborate, and laying out work areas so that people can see one another's work and share lessons learned.

This benchmarking report highlights the following areas of cross- functional team management:

-- Cross-Functional Team Structures

-- Collaboration and Productivity Processes

-- People Management

-- Resource Allocation

-- Decision-Making Processes

-- Communication and Collaboration

For additional sample practices and metrics, download the free study summary at http://www3.best-in-class.com/rr924.htm, or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com for more information.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Exercise and yoga improves quality of life in women with early-stage breast cancer
2. Research highlights important indicators of early-stage ovarian cancer
3. Protein Linked With Poor Prognosis in Early-Stage Breast Cancer
4. OmniGuide Begins European Commercialization
5. Creating Effective Cross-Functional Teams for Pharmaceutical Commercialization Success
6. Anesiva to Unveil Zingo(TM) Commercialization Plans
7. China Medicines ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province
8. IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities
9. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
10. Pharmaceutical Product Commercialization: Enabling Teams to Excel
11. Building Better Launch Teams for Pharmaceutical Commercialization Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 10, 2016 , ... Denver-based humanitarian aid organization, Saving Moses, ... toddlers. , The situation in Syria continues to worsen—deadly weapon explosions are increasing ... from disease. The situation is intensifying with winter coming and airstrikes increasing. ...
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company is ... As a means of expanding capabilities Flottman has added a G&K Vijuk ... code professional inserts (PIs) and patient package inserts (PPIs) that will marry with ...
(Date:12/9/2016)... ... 09, 2016 , ... Mediaplanet today announces distribution of the latest edition of ... sign up as an organ donor for the 123,000 people in the United States ... can save up to 8 saves through organ donation and enhance many others through ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... County, a Property owned by an affiliate of Seavest, has won a prestigious ... Medicine Southern Chester County ambulatory care center (ACC) was named “Best New Development, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 2016 Research and Markets has announced the ... to their offering. ... The global travel vaccines market to grow at a CAGR ... the present scenario and the growth prospects of the global travel ... considers the revenue generated from the sales of various vaccines administered ...
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... , Dec. 8, 2016  The global biosurgery market ... during the forecast period of 2016 to 2021. The ... 2021 from USD 18.21 billion in 2016. The market ... incidences of sports related injuries and spinal problems, increasing ... need of effective blood loss management. In ...
Breaking Medicine Technology: